BevacizumabLack of efficacy: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1942卷 / 1期

关键词：

D O I：

10.1007/s40278-023-32684-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：75 / 75

相关论文

共 50 条

[21] Atezolizumab/bevacizumabLack of efficacy: case report
Reactions Weekly, 2022, 1922 (1) : 104 - 104
[22] Aflibercept/bevacizumabLack of efficacy: case report
Reactions Weekly, 2023, 1957 (1) : 21 - 21
[23] Atezolizumab/bevacizumabLack of efficacy: case report
Reactions Weekly, 2025, 2041 (1) : 70 - 70
[24] Atezolizumab/bevacizumabLack of efficacy: case report
Reactions Weekly, 2022, 1912 (1) : 100 - 100
[25] Acetazolamide/bevacizumabLack of efficacy: case report
Reactions Weekly, 2022, 1913 (1) : 18 - 18
[26] Atezolizumab/bevacizumabLack of efficacy: case report
Reactions Weekly, 2024, 2025 (1) : 60 - 60
[27] Antiglaucoma/acetazolamide/bevacizumabLack of efficacy: case report
Reactions Weekly, 2022, 1926 (1) : 52 - 52
[28] Atezolizumab/bevacizumabLack of efficacy and recurrent pneumothorax: case report
Reactions Weekly, 2024, 2035 (1) : 86 - 86
[29] BevacizumabLack of efficacy and off-label use: case report
Reactions Weekly, 2025, 2042 (1) : 81 - 81
[30] BevacizumabLack of efficacy : 2 case reports
Reactions Weekly, 2023, 1953 (1) : 109 - 109

← 1 2 3 4 5 →